ZA200702971B - Method for treatment with bucindolol based on genetic targeting - Google Patents

Method for treatment with bucindolol based on genetic targeting

Info

Publication number
ZA200702971B
ZA200702971B ZA200702971A ZA200702971A ZA200702971B ZA 200702971 B ZA200702971 B ZA 200702971B ZA 200702971 A ZA200702971 A ZA 200702971A ZA 200702971 A ZA200702971 A ZA 200702971A ZA 200702971 B ZA200702971 B ZA 200702971B
Authority
ZA
South Africa
Prior art keywords
treatment
genetic targeting
bucindolol
bucindolol based
targeting
Prior art date
Application number
ZA200702971A
Inventor
Bristow Michael
Stephen B Liggett
Original Assignee
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Colorado Regents filed Critical Univ Colorado Regents
Publication of ZA200702971B publication Critical patent/ZA200702971B/en

Links

ZA200702971A 2004-09-14 2007-04-11 Method for treatment with bucindolol based on genetic targeting ZA200702971B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60968904P 2004-09-14 2004-09-14

Publications (1)

Publication Number Publication Date
ZA200702971B true ZA200702971B (en) 2009-09-30

Family

ID=38938240

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702971A ZA200702971B (en) 2004-09-14 2007-04-11 Method for treatment with bucindolol based on genetic targeting

Country Status (2)

Country Link
CN (1) CN101087891A (en)
ZA (1) ZA200702971B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106370754B (en) * 2016-11-07 2019-03-08 西安科技大学 Based on chiral high performance liquid chromatography-mass spectrum/mass-spectrometric technique quantitative detection bucindolol optical isomer content method

Also Published As

Publication number Publication date
CN101087891A (en) 2007-12-12

Similar Documents

Publication Publication Date Title
GB0526291D0 (en) Therapeutic method
EP1756738A4 (en) Content-management system for user behavior targeting
GB0402131D0 (en) Delivery method
EP1803244A4 (en) Enciphering method
EP1715799A4 (en) Glaucoma treatment method
IL186542A0 (en) Improved methods controlling gene expression
EP1807966A4 (en) Authentication method
HK1083376A1 (en) Dual-path-pre-approval authentication method
MX305616B (en) Methods for increasing maize yields.
IL183889A0 (en) Treatment method
EP1819639A4 (en) Nebulizing treatment method
WO2007056113A9 (en) Methods for targeting quadruplex sequences
EP1755394A4 (en) Cancer treatment method
HK1117871A1 (en) Methods for delivering genes
EP1765344A4 (en) Cancer treatment method
EP1809276A4 (en) Treatment method
EP1846432A4 (en) Method for making targeted therapeutic agents
ZA200707236B (en) Microorganisms for therapy
GB0406728D0 (en) Gene therapy
ZA200702971B (en) Method for treatment with bucindolol based on genetic targeting
GB0607153D0 (en) Therapeutic Method
IL164850A0 (en) Gene therapy for kidney diseases
GB0606660D0 (en) Targeted Therapy
GB0420822D0 (en) Therapeutic method
GB0420823D0 (en) Therapeutic method